Skip to main content

EP 107 (Acetazolamide Extended Release 500 mg)

Pill with imprint EP 107 is Orange & White, Capsule-shape and has been identified as Acetazolamide Extended Release 500 mg. It is supplied by Zydus Pharmaceuticals.

Acetazolamide is used in the treatment of glaucoma; hydrocephalus; edema; epilepsy; mountain sickness / altitude sickness and belongs to the drug classes carbonic anhydrase inhibitor anticonvulsants, carbonic anhydrase inhibitors. Risk cannot be ruled out during pregnancy. Acetazolamide 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for EP 107

Acetazolamide Extended Release

Imprint
EP 107
Strength
500 mg
Color
Orange & White
Size
25.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants, Carbonic anhydrase inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals
Inactive Ingredients
ammonio methacrylate copolymer type A, ammonio methacrylate copolymer type B, FD&C Yellow No. 6, gelatin, microcrystalline cellulose, sodium lauryl sulfate, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
68382-0261 (Discontinued) Zydus Pharmaceuticals (USA) Inc.
68084-0401 (Discontinued) Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.